C6240
CITCO
≥98% (HPLC), androstane receptor agonist, solid
别名:
6-（4-氯苯基）咪唑并[2，1-b][1，3]噻唑-5-甲醛O-（3，4-二氯苄基）肟
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C19H12N3OCl3S
化学文摘社编号:
分子量:
436.74
UNSPSC Code:
12352203
PubChem Substance ID:
NACRES:
NA.77
MDL number:
产品名称
CITCO, ≥98% (HPLC), solid
Quality Level
assay
≥98% (HPLC)
form
solid
storage condition
desiccated
solubility
DMSO: soluble 28 mg/mL, H2O: insoluble
storage temp.
−20°C
SMILES string
Clc1ccc(cc1)-c2nc3sccn3c2\C=N\OCc4ccc(Cl)c(Cl)c4
InChI
1S/C19H12Cl3N3OS/c20-14-4-2-13(3-5-14)18-17(25-7-8-27-19(25)24-18)10-23-26-11-12-1-6-15(21)16(22)9-12/h1-10H,11H2/b23-10+
InChI key
ZQWBOKJVVYNKTL-AUEPDCJTSA-N
相关类别
General description
CITCO是一种咪唑并噻唑衍生物。它刺激人类组成型雄烷受体（CAR）核易位。
Application
CITCO已用于小鼠组成型雄烷受体（CAR）和人CAR的激活。
Biochem/physiol Actions
CITCO是组成型雄烷受体（CAR）激动剂；核受体NR113激动剂。
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes
Maglich JM, et al.
The Journal of Biological Chemistry, 278(19), 17277-17283 (2003)
Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells
Chakraborty S , et al.
British Journal of Cancer, 104(3), 448-448 (2011)
Constitutive androstane receptor (Car)-driven regeneration protects liver from failure following tissue loss
Tschuor C, et l.
Journal of Hepatology, 65(1), 66-74 (2016)
Tadeja Režen et al.
Drug metabolism and disposition: the biological fate of chemicals, 45(8), 974-976 (2017-05-26)
Statins are well known lipid lowering agents that inhibit the enzyme 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase. They also activate drug metabolism but their exact receptor-mediated action has not been proven so far. We tested whether atorvastatin and rosuvastatin are direct ligands of
Susanne Johansson et al.
Clinical pharmacology in drug development, 6(5), 466-475 (2017-03-17)
Tenapanor (RDX5791, AZD1722) is an inhibitor of sodium/hydrogen exchanger isoform 3 in development for the treatment of constipation-predominant irritable bowel syndrome and the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis. We aimed to investigate whether tenapanor
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| C6240-5MG | 04061833511008 |
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持